Risk factor analysis for pneumococcal meningitis in adults with invasive pneumococcal infection

Epidemiology and Infection

Volumn 138, Issue 9, 2010, Pages 1353-1358

  Burckhardt, I ^a,d   Burckhardt, F ^b   Van Der Linden, M ^a   Heeg, C ^a   Reinert, R R ^a,c  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b EPIET Alumnus   (Germany)

^c Wyeth Vaccines Research   (France)

^d UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Meningitis; multiple logistic regression; pneumococci; population study; risk factor

Indexed keywords

MACROLIDE; PENICILLIN G;

ADULT; AGE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; BACTERIUM ISOLATE; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; FEMALE; GERMANY; HUMAN; INFECTION RISK; MALE; PNEUMOCOCCAL MENINGITIS; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SEASONAL VARIATION; SEROTYPING; SEX DIFFERENCE; STREPTOCOCCUS PNEUMONIAE; ADOLESCENT; AGED; BACTERIAL MENINGITIS; CLASSIFICATION; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; PNEUMOCOCCAL INFECTION; SEASON; STATISTICAL MODEL;

ADOLESCENT; ADULT; AGED; FEMALE; GERMANY; HUMANS; LINEAR MODELS; MALE; MENINGITIS, PNEUMOCOCCAL; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PNEUMOCOCCAL INFECTIONS; PROSPECTIVE STUDIES; RISK FACTORS; SEASONS; SEROTYPING; SEX FACTORS; STREPTOCOCCUS PNEUMONIAE;

EID: 77956635818     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268809991683     Document Type: Article

References (31)

1. World Health Organization. (http://www.who.int/en/). Accessed 23 January 2007.
2. Centers for Disease Control and Prevention. (http://www.cdc.gov/). Accessed 23 January 2007.
3. Musher DM. Streptococcus pneumoniae. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases, 5th edn. USA: Churchill Livingston, 2000, pp. 2128-2147.
4. Obaro S, Adegbola R. The pneumococcus: carriage, disease and conjugate vaccines. Journal of Medical Microbiology 2002;51:98-104.
5. Koedel U, Scheld WM, Pfister HW. Pathogenesis and pathophysiology of pneumococcal meningitis. Lancet infectious diseases 2002;2:721-736.
6. Weisfelt M, et al. Clinical features, complications, and outcome in adults with pneumococcal meningitis: a prospective case series. Lancet Neurology 2006;5:123-129.
7. Auburtin M, et al. Pneumococcal meningitis in the intensive care unit: Prognostic factors of clinical outcome in a series of 80 cases. American Journal of Respiratory and Critical Care Medicine 2002;165:713-717.
8. Weber JR. Pathogenesis of pneumococcal meningitis. In: Tuomanen E, Mitchell TJ, Morrison DA, Spratt BG, eds. The Pneumococcus. Washington, DC: ASM Press, 2004, pp. 238-251.
9. Hammerschmidt S. Adherence molecules of pathogenic pneumococci. Current Opinion in Microbiology 2006;9:12-20.
10. Zhang JR, et al. The polymeric immunoglobulin receptor translocates pneumococci across human nasopharyngeal epithelial cells. Cell 2000;102:827-837.
11. Ring A, Weiser JN, Tuomanen EI. Pneumococcal trafficking across the blood-brain barrier. Molecular analysis of a novel bidirectional pathway. Journal of Clinical Investigation 1998;102:347-360.
12. Cundell DR, et al. Streptococcus pneumoniae anchor to activated human cells by the receptor for plateletactivating factor. Nature 1995;377:435-438.
13. de Roux A, et al. Impact of alcohol abuse in the etiology and severity of community-acquired pneumonia. Chest 2006;129:1219-1225.
14. Grabowska K, et al. Occurrence of invasive pneumococcal disease and number of excess cases due to influenza. BMC Infectious Disease 2006;6:58.
15. Ortqvist A, Hedlund J, Kalin M. Streptococcus pneumoniae: epidemiology, risk factors, and clinical features. Seminars in Respiratory and Critical Care Medicine 2005;26:563-574.
16. Trampuz A, et al. Changes in the epidemiology of pneumococcal bacteremia in a swiss university hospital during a 15-year period, 1986-2000. Mayo Clinic Proceedings 2004;79:604-612.
17. Federal Statistical Office of Germany (Statistisches Bundesamt Deutschland). (https://www-genesis.destatis. de). Accessed 9 September 2009.
18. CLSI. Performance standards for antimicrobial susceptibility testing; fifteenth informational supplement. M100-S15 edn. Clinical and Laboratory Standards Institute, USA, 2005, p. 163.
19. STIKO. Recommendations of the German Standing Vaccination Committee at the Robert-Koch Institute, July 2009 [in German]. Epidemiologisches Bulletin 2009;30:279-298.
20. Butler JC. Epidemiology of pneumococcal disease. In: Tuomanen E, Mitchell TJ, Morrison DA, Spratt BG, eds. The Pneumococcus. Washington, DC: ASM Press, 2004, pp. 148-168.
21. Klein S. Host factors mediating sex differences in viral infection. Gender Medicine 2005;2:197-207.
22. Valles X, et al. Hospitalized community-acquired pneumonia due to Streptococcus pneumoniae: has resistance to antibiotics decreased? Chest 2006;130:800-806.
23. Craig L. Parental education, time in paid work and time with children: an australian time-diary analysis. British Journal of Sociology 2006;57:553-575.
24. Bogaert D, De Groot R, Hermans PW. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infectious Diseases 2004;4:144-154. (Pubitemid 38293138)
25. Reinert RR, et al. Invasive pneumococcal disease in adults in north-Rhine Westphalia, Germany, 2001-2003. Clinical Microbiology and Infection 2005;11:985-991.
26. Annual Report. Annual report of the national reference centre for streptococci, 2005, Aachen, German.
27. Jarva H, et al. Complement resistance mechanisms of streptococci. Molecular Immunology 2003;40:95-107.
28. Musher DM, et al. Antibody to capsular polysaccharides of streptococcus pneumoniae: prevalence, persistence, and response to revaccination. Clinical Infectious Diseases 1993;17:66-73.
29. Bermpohl D, et al. Bacterial programmed cell death of cerebral endothelial cells involves dual death pathways. Journal of Clinical Investigation 2005;115:1607-1615.
30. Weiser JN, et al. Phase variation in pneumococcal opacity: relationship between colonial morphology and nasopharyngeal colonization. Infection & Immunity 1994;62:2582-2589.
31. Kim JO, Weiser JN. Association of intrastrain phase variation in quantity of capsular polysaccharide and teichoic acid with the virulence of Streptococcus pneumoniae. Journal of Infectious Diseases 1998;177:368-377.